Updated Survival, Quality of Life (QOL), and Safety Data of Radium-223 Chloride (RA-223) in Patients with Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases from the Phase 3 Double-Blind, Randomized, Multinational Study (ALSYMPCA)

Chris Parker, Robert E. Coleman, Sten Nilsson, Nicholas J. Vogelzang, Andrew Lloyd, K. Staudacher, R. Van Gool, Oliver Sartor

Annals of Oncology · 2012 · 17 citations · 0 references

DOIFull text

Open access

Concepts